Assessment of the optimal number of positive biopsy cores to discriminate between cancer‐specific mortality in high‐risk versus very high‐risk prostate cancer patients-Reference-Cited by-同舟云学术

Assessment of the optimal number of positive biopsy cores to discriminate between cancer‐specific mortality in high‐risk versus very high‐risk prostate cancer patients

Published:2021-07-26 Issue:14 Volume:81 Page:1055-1063
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Wenzel Mike¹²^ORCID,Würnschimmel Christoph²³^ORCID,Chierigo Francesco²⁴,Tian Zhe²,Shariat Shahrokh F.⁵⁶⁷⁸⁹,Terrone Carlo⁴,Saad Fred²,Tilki Derya³¹⁰^ORCID,Graefen Markus³,Roos Frederik C.¹,Kluth Luis¹,Mandel Philipp¹,Chun Felix K. H.¹,Karakiewicz Pierre I.²

Affiliation:

1. Department of Urology University Hospital Frankfurt Frankfurt am Main Germany

2. Division of Urology, Cancer Prognostics and Health Outcomes Unit University of Montréal Health Center Montréal Québec Canada

3. Martini‐Klinik Prostate Cancer Center University Hospital Hamburg‐Eppendorf Hamburg Germany

4. Department of Urology, Policlinico San Martino Hospital University of Genova Genova Italy

5. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria

6. Departments of Urology Weill Cornell Medical College New York New York USA

7. Department of Urology University of Texas Southwestern Dallas Texas USA

8. Department of Urology, Second Faculty of Medicine Charles University Prag Czech Republic

9. Department of Urology, Institute for Urology and Reproductive Health I. M. Sechenov First Moscow State Medical University Moscow Russia

10. Department of Urology University Hospital Hamburg‐Eppendorf Hamburg Germany

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24202

Reference25 articles.

1. Prostate cancer, version 1.2020, NCCN clinical practice guidelines in oncology;Mohler JL;J Natl Compr Canc Netw,2020

2. Very-high-risk localized prostate cancer: definition and outcomes

3. Superior survival benefits of Radical Prostatectomy than External Beam Radiotherapy in aging 75 and older men with high-risk or very high-risk Prostate Cancer: a population-matched study

4. Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity

5. High‐dose‐rate brachytherapy and hypofractionated external beam radiotherapy combined with long‐term androgen deprivation therapy for very high‐risk prostate cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer;Journal of Urology;2022-02

2. Re: Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?;Prostate Cancer and Prostatic Diseases;2022-01-23

3. The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate Cancer;Frontiers in Oncology;2021-10-06